Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.

Hiroki IidaYoshihito SakaiTaisuke SekiTsuyoshi WatanabeNorimitsu WakaoHiroki MatsuiShiro Imagama

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2022)

BP medication is beneficial not only for fracture prevention but also for mortality after OVF.

Keyphrases

end stage renal disease
newly diagnosed
bone mineral density
chronic kidney disease
prognostic factors
healthcare
cardiovascular events
risk factors
body composition
postmenopausal women